NCT02103634View on ClinicalTrials.gov

NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2014

Primary Completion Date

December 21, 2018

Study Completion Date

December 21, 2018

Conditions

Malignant Neoplasm of Breast TNM Staging Distant Metastasis (M)Untreated Bone Metastases

Interventions

DEVICE

NaF PET/MRI

DEVICE

NaF PET/CT

NaF PET/CT images will be obtained through fusion software. Researchers will fuse the Non AC and AC NaF images with the low dose CT obtained in the FDG PET/CT study.

DEVICE

FDG PET/CT

Trial Locations (1)

44106

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT02103634 - NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer | Biotech Hunter | Biotech Hunter